Best Penny Stocks To Watch Today - January 2nd

Key Points

• MarketBeat's screener identifies Sidus Space (SIDU), Brand Engagement Network (BNAI), and Ironwood Pharmaceuticals (IRWD) as the penny stocks to watch today, based on the highest dollar trading volume among penny stocks in recent days.
• Sidus Space is a space-as-a-service company offering satellite hardware, LEO launches and geospatial data services; Brand Engagement Network develops security-focused conversational AI assistants; and Ironwood markets the GI drug LINZESS for IBS-C and chronic idiopathic constipation.
• Penny stocks are typically low-priced and thinly traded and are highly speculative, with extreme volatility, low liquidity, limited public information, and greater susceptibility to fraud, so they suit only risk-tolerant investors.

Sidus Space, Brand Engagement Network, and Ironwood Pharmaceuticals are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small, often thinly traded companies—commonly quoted at under a few dollars per share—and are frequently traded over-the-counter or on less-regulated exchanges. They carry high risk due to extreme price volatility, low liquidity, limited public information, and greater susceptibility to fraud, making them primarily speculative investments. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Sidus Space (SIDU)

Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.

Read Our Latest Research Report on SIDU

Brand Engagement Network (BNAI)

Brand Engagement Network, Inc. provides conversational AI assistants. The company offers security-focused, multimodal communication, and human-like assistants. Its AI assistants are built on proprietary natural language processing, anomaly detection, multisensory awareness, sentiment, and environmental analysis, as well as real-time individuation and personalization capabilities.

Read Our Latest Research Report on BNAI

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries.

Read Our Latest Research Report on IRWD